Article History
Accepted: 3 November 2020
First Online: 14 December 2020
Competing interests
: V.S. declares that she has received consulting fees from AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Celgene, Celltrion, Crescendo/Myriad, EMD Serono, Equillium, Galapagos, Genentech/Roche, Gilead, GSK, Horizon, Ichnos, Inmedix, Janssen, Lilly, Merck, Novartis, Pfizer, Regeneron, Samsung, Sandoz, Sanofi, Servier, Setpoint and UCB. J.G. declares that he has received financial support for research projects from AstraZeneca, Biogen and Shire (Takeda). J.G. has also received consulting fees from Amgen, Biogen, Fresenius, Novartis, Samsung Bioepis and Sanofi. J.D.I. declares that he has received research funding from Pfizer and consulting or speaker fees from AbbVie, Amgen, Merck, Roche and UCB.